Auricle

Auricle is a pioneering medical device company dedicated to developing a revolutionary neurostimulation implant. This innovative device aims to restore hearing for millions of individuals who no longer experience sufficient benefit from traditional hearing aids. Specifically, it targets patients scoring below 60% on word recognition tests but who are hesitant to undergo cochlear implant surgery.

Auricle's unique approach focuses on preserving any remaining natural hearing through a minimally invasive and reversible surgical procedure. This addresses the primary concerns that often deter patients from opting for cochlear implants, which are currently the only available treatment for this specific patient demographic.

Originating from Stanford Biodesign, Auricle has already completed two acute human clinical studies, demonstrating the potential efficacy of its approach. The company is now concentrating on the development of a comprehensive implant system in preparation for its initial clinical trial. Auricle is poised to address a currently underserved segment of the hearing loss market, encompassing an expanding population of 3.5 million individuals in the United States, representing an immediately accessible $1.2 billion market opportunity with established reimbursement pathways.